Endocrinologist News and Research

RSS

Researchers identify how promising therapy may work to improve adverse effects of NAFLD

A team led by researchers at Massachusetts General Hospital (MGH) has taken an important step forward in the goal of developing a potential treatment for non-alcoholic fatty liver disease (NAFLD), the most common form of chronic liver disease.

26 Aug 2020

America’s obesity epidemic threatens effectiveness of any COVID vaccine

For a world crippled by the coronavirus, salvation hinges on a vaccine.

6 Aug 2020

Developing a Better Understanding of Polycystic Ovary Syndrome (PCOS)

In this interview, Dr. Andrea Dunaif talks to News-Medical about their genetic analysis study which suggests there are different subtypes of PCOS.

20 Jul 2020

Stress hormone is a crucial component of diabetes management, shows study

A new study by researchers at The Ohio State University Wexner Medical Center and The Ohio State University College of Medicine documents a clear link between the stress hormone cortisol and higher blood sugar levels in people with type 2 diabetes.

13 Jul 2020

7 in 10 U.S. adults worry poor health will limit their life experiences, survey finds

Seven in 10 U.S. adults worry poor health will prevent them from doing all the things they'd like to do in life, according to a new survey from the American Heart Association and American Diabetes Association.

7 Jul 2020

New guidelines on assessment and management of type 2 diabetes in children, adolescents

A team of paediatric specialists, including an expert from the University of Adelaide, has produced new guidelines regarding assessment and management of type 2 diabetes (T2D) in Australian and New Zealand children and adolescents.

6 Jul 2020

Chemist develops new drug to treat type 2 diabetes without undesired side effects

Syracuse University chemistry professor Dr. Robert P. Doyle has developed a new drug lead to treat type 2 diabetes in millions of patients who are seeking to better control their blood sugar without the common side effects of nausea, vomiting, and in select cases, undesired weight loss.

23 Jun 2020

Anti-TNF drug preserves beta-cell function in newly diagnosed pediatric patients with Type 1 diabetes

In research led by a University at Buffalo pediatric endocrinologist, a drug called golimumab showed that it preserved beta-cell function in children and young adults with newly diagnosed Type 1 diabetes, according to findings from a Phase 2 study.

16 Jun 2020

New AI algorithm could help people with type 1 diabetes better manage their glucose levels

Researchers and physicians at Oregon Health & Science University, using artificial intelligence and automated monitoring, have designed a method to help people with type 1 diabetes better manage their glucose levels.

14 Jun 2020

COVID ‐19 stay‐at‐home orders influence health behaviors of patients with obesity

Shelter-in-place orders to reduce the spread of COVID-19 put unusual strains on people with obesity, making it more difficult for them to eat properly and manage their weight, according to a UT Southwestern study.

11 Jun 2020

COVID-19 pandemic impacts mental, physical health of people with obesity

The COVID-19 pandemic is having a significant impact on people with obesity as they struggle to manage their weight and mental health during shelter-in-place orders, according to research led by The University of Texas Health Science Center at Houston and UT Southwestern.

10 Jun 2020

Transition to virtual care during COVID-19 does not limit glycemic outcomes of diabetes inpatients

Data collected over a 15-week period showed that using virtual care to manage diabetes patients in the hospital does not have a negative impact on their glycemic outcomes.

15 May 2020

Indian physicians’ petition puts focus on race risks in the wake of COVID-19

A group of leading, ethnic Indian physicians has petitioned Britain's National Health Service (NHS) to formally include ethnicity as a COVID-19 infection risk factor for healthcare workers in the UK.

5 May 2020

Could DPP4 inhibitors help treat COVID-19?

Researchers and clinicians are scrambling to find ways to combat COVID-19, including new therapeutics and eventually a vaccine.

13 Apr 2020

Mayo Clinic highlights the impact of false-negative COVID-19 test results

As COVID-19 testing becomes more widely available, it's vital that health care providers and public health officials understand its limits and the impact false results can have on efforts to curb the pandemic.

9 Apr 2020

Wearable delivery device allows adults with type 2 diabetes to safely use affordable insulin therapy

Adults with type 2 diabetes requiring insulin therapy can safely achieve good blood sugar control using regular human insulin (RHI) in a wearable, patch-like insulin delivery device called V-Go®, a new study finds.

31 Mar 2020

Drone delivers insulin for diabetic patient living in a remote community

The international medical team that accomplished the world's first documented drone delivery of insulin for a patient living in a remote community described the project in an ENDO 2020 abstract that will be published in the Journal of the Endocrine Society.

30 Mar 2020

Has COVID-19 affected diabetes care?

The COVID-19 pandemic is rampaging across continents, leaving death, fear, and uncertainty in its wake. The virus is known to cause more severe illness and have a higher death rate in people who are already sick or immunocompromised, as well as the elderly. Several nations, states, and provinces have announced total lockdowns to try and minimize the impact of the virus.

29 Mar 2020

Hormone blocker shocker: Drug costs 8 times more when used for kids

Dr. Sudeep Taksali, an orthopedic surgeon, became worried that his 8-year-old daughter had already grown taller than his 12-year-old son. And sometimes she had an attitude more befitting a teenager. Something seemed wrong.

24 Feb 2020

Patients with type 2 diabetes who decline insulin therapy had worse blood sugar control

Patients with type 2 diabetes who have high levels of blood sugar are at greater risk of serious complications such as chronic kidney disease, heart disease and blindness.

20 Feb 2020